Breast Cancer:Advances in Research and Treatment, Vol. 2: Experimental Biology 1978
DOI: 10.1007/978-1-4757-4673-0_1
|View full text |Cite
|
Sign up to set email alerts
|

Hormones and Mammary Carcinogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
9
0

Year Published

1992
1992
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(9 citation statements)
references
References 28 publications
0
9
0
Order By: Relevance
“…Concerning the a-CD and HP-a-CD, binding constants (K 1 , respectively. Moreover, no enantioseparation is observed.…”
Section: Determination Of Apparent and Averaged Binding Constantsmentioning
confidence: 99%
“…Concerning the a-CD and HP-a-CD, binding constants (K 1 , respectively. Moreover, no enantioseparation is observed.…”
Section: Determination Of Apparent and Averaged Binding Constantsmentioning
confidence: 99%
“…1) [1] have been developed as inhibitors of P450 aromatase [2,3] and are useful in second-line therapy of estrogen-dependent breast cancer in postmenopausal women [4]. The need for clinical drugs with increased specificity, clinical efficiency, and tolerability remains a challenge in the development of new compounds [3,5] and lead us to synthesize new benzoxazolinone (1, 3, 5-10) and benzothiazolinone (2, 4) derivatives ( Fig. 1) [6,7] which present higher in vitro activities than fadrozole.…”
Section: Introductionmentioning
confidence: 99%
“…Animal studies and clinical trials of anti-oestrogens and inhibitors of oestrogen biosynthesis have confirmed that oestrogens are the most important hormones involved in supporting growth of hormone-dependent breast cancers (Segaloff, 1978;Kirschner, 1979). Indeed, oestrogen deprivation by these means results in objective tumour regression.…”
mentioning
confidence: 97%